Journal profile · OTORHINOLARYNGOLOGY

International Forum of Allergy & Rhinology

ISSN 2042-6976 · eISSN 2042-6984 · Wiley-Blackwell · UNITED STATES

International Forum of Allergy & Rhinology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.91; hybrid open access; APC about USD 4,100; median 87 days to acceptance (93 articles, last 24 months); community-reported acceptance: easy; 243 articles in 2025; indexed in SCIE and Scopus.

Impact factor4.91Latest value listed by LetPub
CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine
Review time87 daysMedian, submission to acceptance · 93 articles, last 24 months · Crossref
APCUSD 4,100Hybrid journal: charged only for open-access articles
AcceptanceEasyCommunity average
Articles per year2432025 · OpenAlex count

Scope

Aims, scope and focus

International Forum of Allergy & Rhinology is published by Wiley-Blackwell and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sinusitis and nasal conditions, Nasal Surgery and Airway Studies and Allergic Rhinitis and Sensitization, together about 55.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

International Forum of Allergy & Rhinologyis a peer-reviewed scientific journal, and the Official Journal of the American Rhinologic Society and the American Academy of Otolaryngic Allergy. International Forum of Allergy Rhinology provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions. The application of current research to the management of otolaryngic allergy, rhinologic, and skull base diseases and the need for further investigation will be highlighted. Abstracting and Indexing Information Embase (Elsevier) EMCare (Elsevier) Health & Medical Collection (ProQuest) Health Research Premium Collection (ProQuest) Hospital Premium Collection (ProQuest) MEDLINE/PubMed (NLM) ProQuest Central (ProQuest) Science Citation Index Expanded (Clarivate Analytics) SCOPUS (Elsevier) Web of Science (Clarivate Analytics)

From the journal's Aims & Scope

Research area (LetPub): OTORHINOLARYNGOLOGY

Editor-in-chief Timothy L. SmithPublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Sinusitis and nasal conditionsMedicine29.1%
  2. Nasal Surgery and Airway StudiesMedicine14.2%
  3. Allergic Rhinitis and SensitizationMedicine12.4%
  4. Head and Neck Surgical OncologyMedicine10%
  5. Olfactory and Sensory Function StudiesNeuroscience7.5%
  6. Asthma and respiratory diseasesMedicine5.6%
  7. Cystic Fibrosis Research AdvancesMedicine3.5%
  8. Respiratory and Cough-Related ResearchMedicine2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorOtorhinolaryngologyZone 1

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorOtorhinolaryngologyZone 1

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorOtorhinolaryngologyZone 1

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

Web of ScienceMEDLINEPubMedEmbasePublisher website

Other: ProQuest

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
4.91LetPub ·
Impact factor (publisher)
4.9Publisher website ·
Impact factor (publisher) 2025
4.9Publisher website ·
CiteScore 2026-06
6.6LetPub ·
CiteScore (publisher)
6.6Publisher website ·
CiteScore (publisher) 2025
6.6Publisher website ·
SJR 2026-06
1.43LetPub ·
SNIP 2026-06
1.68LetPub ·
h-index
34LetPub ·
h-index
94OpenAlex ·
i10-index
1,542OpenAlex ·
2-year mean citedness
2.03OpenAlex ·
Self-citation rate
12.2%LetPub ·
Share of gold OA articles
34.16%LetPub ·

Volume

Articles per year
131LetPub ·
Articles per year (publisher) 2025
220Publisher website ·
Downloads per year (publisher) 2025
447,836Publisher website ·

Articles by year OpenAlex count · 3,199 in total · the current year is incomplete

YearArticlesOpen accessCitations
202619511952
2025243137431
2024208134829
20231951201,969
2022182682,378
2021218742,875

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

87 daysMedian, submission to acceptance · P25–P75 51 days – 116 days

Acceptance to online
median 15 days (93 articles)
Submission to online
median 104 days
Sample
93 articles with submission and acceptance dates (477 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·
Acceptance rate (publisher)
22%Publisher website ·
Acceptance rate (publisher) 2025
22%Publisher website ·
Submission to first decision
6 daysPublisher website ·
Submission to first decision 2025
6 daysPublisher website ·
Submission to acceptance 2025
84 daysPublisher website ·
Acceptance to publication 2025
15 daysPublisher website ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 4,100 / EUR 3,400 / GBP 2,720——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted3, with length limits
  1. research articlelysis are included under this category. Research articles are generally 3500 words or fewer, exclusive of tables, figures, and references, andmain text ≤ 3,500 words
  2. research articlesResearch Articles These reports typically include randomized trials, intervention studies, cohort studies, case-control studies, epidemiologic assessments, othe…Length not stated
  3. review articlesReview Articles Review Articles of variousLength not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship
Authorship

Originality requirement Model summary

Material submitted to International Forum of Allergy & Rhinology must be original and not published or submitted for publication elsewhere.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Wiley-Blackwell
Country or region
UNITED STATES
Language
English
ISSN
2042-6976
Electronic ISSN
2042-6984
Society / sponsor
American Rhinologic Society
Latest issue on the website
Volume 16, Issue 9 (September 2026)
Official links

FAQ

Frequently asked questions about International Forum of Allergy & Rhinology

What CAS zone is International Forum of Allergy & Rhinology in?

In the 2025 upgraded edition of the CAS Journal Ranking, International Forum of Allergy & Rhinology is in Zone 2 of Medicine, and in Zone 1 of the minor category Otorhinolaryngology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of International Forum of Allergy & Rhinology?

The latest impact factor listed by LetPub is 4.91; CiteScore 6.6, h-index 94.

How long does peer review take at International Forum of Allergy & Rhinology?

Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 51–116 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 22% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index International Forum of Allergy & Rhinology?

According to LetPub and DOAJ records, International Forum of Allergy & Rhinology is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed and Embase; that list has not been checked against each database.

Is International Forum of Allergy & Rhinology open access, and what is the APC?

International Forum of Allergy & Rhinology is a hybrid journal. For open-access publication: APC about USD 4,100.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .